Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Carleton JC Hsia, PhD, Li Ma, PhD

Blood (2018) 132 (Supplement 1): 2355.

https://doi.org/10.1182/blood-2018-99-120287

Published: 2018

Journal Articles

Predictive Value of Natriuretic Peptide Level Monitoring in Patients with Malignant Lymphoma during High-Dose Chemotherapy in Combination with Autologous Stem Cell Transplantation

Dina Kolesnikova, MD

Blood (2017) 130 (Supplement 1): 5466.

https://doi.org/10.1182/blood.V130.Suppl_1.5466.5466

Published: 2017

Journal Articles

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Giovanni Palladini, MDPhD, Marco Basset, MD, Paolo Milani, MD, Marzia Varettoni, MD, Silvia Mangiacavalli, MD, Francesca Russo, MD, Andrea Foli, MD, Alessandro Corso, MD, Giampaolo Merlini, MD

Blood (2017) 130 (Supplement 1): 1760.

https://doi.org/10.1182/blood.V130.Suppl_1.1760.1760

Published: 2017

Journal Articles

Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Blood (2017) 130 (Supplement 1): 1855.

https://doi.org/10.1182/blood.V130.Suppl_1.1855.1855

Published: 2017

Journal Articles

The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction

Michaela Liedtke, MD, Giampaolo Merlini, MD, Heather Landau, MD, Raymond L. Comenzo, MD, Vaishali Sanchorawala, MD, Brendan M. Weiss, MD, Jeffrey A. Zonder, MD, Jackie Walling, MBChB, PhD, Gene G. Kinney, PhD, Martin Koller, MD MPH, Morie A. Gertz, MD MACP

Blood (2016) 128 (22): 5690.

https://doi.org/10.1182/blood.V128.22.5690.5690

Published: 2016

Journal Articles

Diffuse Myocardial Fibrosis Is a Common Feature of Sickle Cell Anemia That Is Associated with Diastolic Dysfunction and Restrictive Cardiac Physiology

Omar Niss, MD, Michael D. Taylor, MD, Robert Fleck, MD, Tarek Alsaied, MD, Jeffrey Towbin, MD, Punam Malik, MD, Charles T. Quinn, MD MS

Blood (2016) 128 (22): 8.

https://doi.org/10.1182/blood.V128.22.8.8

Published: 2016

Journal Articles

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Eric J Chow, MD MPH, David R. Doody, MS, Saro H. Armenian, DO, MPH, Sanjeev Aggarwal, MD, K. Scott Baker, MD MS, Smita Bhatia, MD MPH, Nancy A. Blythe, BA, Louis S. Constine, MD, David R. Freyer, DO, MS, Lisa M. Kopp, DO, Wendy M. Leisenring, ScD, Nao Sasaki, MD, Lynda M. Vrooman, MD MSc, Barbara L. Asselin, MD, Cindy L. Schwartz, MD MPH, Steven E. Lipshultz, MD FAAP, FAHA

Blood (2016) 128 (22): 696.

https://doi.org/10.1182/blood.V128.22.696.696

Published: 2016

Journal Articles

Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center

Victor H Jimenez Zepeda, MD, Peter Duggan, MD, Paola E. Neri, MD PhD, Nizar J Bahlis, MD

Blood (2014) 124 (21): 4743.

https://doi.org/10.1182/blood.V124.21.4743.4743

Published: 2014

Journal Articles

B Type Natriuretic Peptide (BNP) Less Than 200 Pg/Ml Represents Good Candidate For High Dose Melphalan and Predicts Longer Survival In Systemic Light Chain Amyloidosis

Toshiaki Hayashi, M.D., Ph.D., Hiroshi Ikeda, M.D., Ph.D., Yuka Aoki, M.D., Ph.D., Yumiko Maruyama, M.D., Ph.D., Tadao Ishida, M.D., Ph.D., Yasuhisa Shinomura, M.D., Ph.D.

Blood (2013) 122 (21): 5523.

https://doi.org/10.1182/blood.V122.21.5523.5523

Published: 2013

Journal Articles

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

Ashutosh D. Wechalekar, Stefan O. Schonland, Efstathios Kastritis, Julian D. Gillmore, Meletios A. Dimopoulos, Thirusha Lane, Andrea Foli, Darren Foard, Paolo Milani, Lisa Rannigan, Ute Hegenbart, Philip N. Hawkins, Giampaolo Merlini, Giovanni Palladini

Blood (2013) 121 (17): 3420–3427.

https://doi.org/10.1182/blood-2012-12-473066

Published: 2013

Journal Articles

MR-Proanp and VEGF As Markers of Response to MEL-DEX Treatment in Systemic AL Amyloidosis

Alessandro Moscetti, MD, Giusy Antolino, MD, Federica Resci, MD, Daniela De Benedittis, Virginia Naso, MD, Maria Paola Bianchi, MD, Beatrice Musumeci, MD, Francescaromana Festuccia, MD, Gerardo Salerno, Maria Teresa Corsetti, Patrizia Cardelli, MD, Giovanna Ferranti, MD, Giacinto La Verde, MD

Blood (2012) 120 (21): 4970.

https://doi.org/10.1182/blood.V120.21.4970.4970

Published: 2012

Journal Articles

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

Sumit Madan, Shaji K. Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, S. Vincent Rajkumar, William J. Hogan, Nelson Leung, Martha Grogan, Morie A. Gertz

Blood (2012) 119 (5): 1117–1122.

https://doi.org/10.1182/blood-2011-07-370031

Published: 2012

Journal Articles

Non-Pegylated Liposomal Encapsulated Doxorubicin Reduces Cardiotoxicity in 1st Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Final Results of a Randomized Trial

Michael A. Fridrik, MD, Andreas L Petzer, M.D., Felix Keil, MD, Wolfgang Willenbacher, MD, Ulrich Jaeger, MD, Alois Lang, MD, Sonja Burgstaller, MD, Johannes Andel, MD, Otto Krieger, M.D., Wilhelm Oberaigner, Richard Greil, MD

Blood (2011) 118 (21): 2676.

https://doi.org/10.1182/blood.V118.21.2676.2676

Published: 2011

Journal Articles

The Timing of Acute Renal Failure Strongly Affects Survival of Immunoglobulin Light Chain (AL) Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation,

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, MD, Martha Q Lacy, MD, Francis K Buadi, M.D., Suzanne R Hayman, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis A. Gastineau, MD, Siobhan V Glavey, M.B., B. Ch, Morie A Gertz, MD

Blood (2011) 118 (21): 4120.

https://doi.org/10.1182/blood.V118.21.4120.4120

Published: 2011

Journal Articles

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Blood (2010) 116 (21): 1639.

https://doi.org/10.1182/blood.V116.21.1639.1639

Published: 2010

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Plasma Level of NT-Pro-BNP In Children with Sickle Cell Disease Is Associated with Degree of Anemia and Left Ventricular Measures: The PUSH Study

Gregory J. Kato, MD, Craig Sable, MD, Gregory Ensing, MD, Niti Dham, MD, Caterina Minniti, MD, Alan Remaley, MD, Andrew Campbell, MD, Manuel Arteta, MD, Sohail Rana, MD, Deepika Darbari, MD, Mehdi Nouraie, MD, Onyinye Onyekwere, MD, Mark Gladwin, MD, Oswaldo Castro, MD, Victor R. Gordeuk, MD

Blood (2010) 116 (21): 948.

https://doi.org/10.1182/blood.V116.21.948.948

Published: 2010

Journal Articles

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Ebru Koca, Gaurav Parikh, Ali Imran Amjad, Floralyn L Mendoza, Chitra M Hosing, Uday Popat, Richard E Champlin, Sergio Giralt, Muzaffar H. Qazilbash

Blood (2008) 112 (11): 4457.

https://doi.org/10.1182/blood.V112.11.4457.4457

Published: 2008

Journal Articles

Natriuretic Peptides as Well as Endothelin, and Not Troponin Are of Value in Early Diagnosis of Acute Cardiotoxicity in Children Undergoing Hematopoietic Stem Cell Transplantation

Agnieszka Zaucha-Prazmo, Katarzyna Drabko, Elzbieta Sadurska, Jerzy R Kowalczyk

Blood (2008) 112 (11): 4300.

https://doi.org/10.1182/blood.V112.11.4300.4300

Published: 2008

Journal Articles

N-Terminal-ProB-Type Natriuretic Peptide as a Marker for Anthracycline Cardiotoxicity in Children with Acute Lymphoblastic Leukaemia

Teresa Jackowska, Malgorzata Golabek, MD

Blood (2008) 112 (11): 3965.

https://doi.org/10.1182/blood.V112.11.3965.3965

Published: 2008

NARROW

SOD3-Mimetic As a Complement for Genetic Therapy in Sickle Cell Disease

Predictive Value of Natriuretic Peptide Level Monitoring in Patients with Malignant Lymphoma during High-Dose Chemotherapy in Combination with Autologous Stem Cell Transplantation

Biomarker-Based Screening of Organ Dysfunction in Patients with MGUS Allows Early Diagnosis of AL Amyloidosis

Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

The VITAL Amyloidosis Study: A Randomized, Double-Blind, Placebo-Controlled, Global, Phase 3 Study of NEOD001 in Patients with AL Amyloidosis and Cardiac Dysfunction

Diffuse Myocardial Fibrosis Is a Common Feature of Sickle Cell Anemia That Is Associated with Diastolic Dysfunction and Restrictive Cardiac Physiology

Effect of Dexrazoxane on Heart Function Among Long-Term Survivors of Childhood Leukemia and Lymphoma: A Report from the Children's Oncology Group (COG)

Bortezomib Containing Regimens Are Highly Effective for Systemic AL Amyloidosis: Experience from a Single Center

B Type Natriuretic Peptide (BNP) Less Than 200 Pg/Ml Represents Good Candidate For High Dose Melphalan and Predicts Longer Survival In Systemic Light Chain Amyloidosis

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

MR-Proanp and VEGF As Markers of Response to MEL-DEX Treatment in Systemic AL Amyloidosis

High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement

Non-Pegylated Liposomal Encapsulated Doxorubicin Reduces Cardiotoxicity in 1st Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Final Results of a Randomized Trial

The Timing of Acute Renal Failure Strongly Affects Survival of Immunoglobulin Light Chain (AL) Amyloidosis Patients Undergoing Autologous Stem Cell Transplantation,

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Plasma Level of NT-Pro-BNP In Children with Sickle Cell Disease Is Associated with Degree of Anemia and Left Ventricular Measures: The PUSH Study

Role of Brain-Type Natriuretic Peptide and Cardiac Troponins as Predictors of Outcome in Multiple Myeloma

Natriuretic Peptides as Well as Endothelin, and Not Troponin Are of Value in Early Diagnosis of Acute Cardiotoxicity in Children Undergoing Hematopoietic Stem Cell Transplantation

N-Terminal-ProB-Type Natriuretic Peptide as a Marker for Anthracycline Cardiotoxicity in Children with Acute Lymphoblastic Leukaemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only